Recursion Pharmaceuticals Stock (NASDAQ: RXRX) stock price, news, charts, stock research, profile.
You can purchase shares of Recursion Pharmaceuticals (NASDAQ:RXRX) through any online brokerage.
Other companies in Recursion Pharmaceuticals’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), Centessa Pharmaceuticals (NASDAQ:CNTA), SpringWorks Therapeutics (NASDAQ:SWTX) and Protagonist Therapeutics (NASDAQ:PTGX).
Recursion Pharmaceuticals has a consensus price target of $12.00.
The stock price for Recursion Pharmaceuticals (NASDAQ: RXRX) is $6.06 last updated December 20, 2024 at 7:58 PM EST.
There are no upcoming dividends for Recursion Pharmaceuticals.
Recursion Pharmaceuticals’s Q4 earnings are confirmed for Tuesday, February 25, 2025.
There is no upcoming split for Recursion Pharmaceuticals.
Recursion Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.